Flu's dirty secret: study probes why ICU patients get deadly fungus
NCT ID NCT03748069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is trying to understand why some people with severe flu in the ICU develop a dangerous fungal lung infection called aspergillosis. Researchers will compare the immune systems of 45 flu patients and non-flu pneumonia patients in the ICU. They hope to find differences in immune cells and function that explain the higher risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitaire Ziekenhuizen Leuven
RECRUITINGLeuven, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu vaccine showdown: which shot protects seniors best?
- Can inhaled nitric oxide speed pneumonia recovery?
- Pneumonia culprit may be rarer than doctors think
- Shorter antibiotic course may be just as effective for kids with pneumonia
- Shocking muscles back to health: could zaps help seniors recover from lung illness?
- New breathing device may reduce need for ventilator in pneumonia patients